Full name
NEURAXPHARM POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
NEURAXPHARM POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. POLECZKI 35, 02-822 WARSZAWA
TAX ID5213862834
Rate company:
NEURAXPHARM POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5213862834
KRS0000792637
Share capital5,000.00 zł
address
UL. POLECZKI 35, 02-822 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5213862834
REGON
383025598
KRS
0000792637
Legal form
limited liability company
Register Address
UL. POLECZKI 35, 02-822 WARSZAWA
Date of registration in KRS
2019-07-01
Date of commencement of economic activity
2019-07-01
Act signature
RDF/619457/24/388
Pkd codes
73.11.Z - Advertising agencies activities
58.14.Z - Publishing of journals and periodicals
63.12.Z - Web portals
70.21.Z - Public relations and communication activities
70.22.Z - Business and other management consultancy activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.30.Z - Organisation of conventions and trade shows
85.60.Z - Educational support activities
Payer VAT status
Active
Vat list bank account(s)
PL69 1050 1025 1000 0090 3232 6895 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 8,6 | 9,5 | 9,4 | -0,9 |
Gross profit (loss) | 1,6 | 1,7 | 2,5 | 48,2 |
EBITDA | 2,3 | 2,8 | 3,4 | 21,3 |
Net profit (loss) | 1,3 | 1,2 | 1,8 | 49,8 |
Cash | 3,7 | 4 | 3,5 | -13,4 |
Liabilities and provisions for liabilities | 6,5 | 6 | 4,1 | -32 |
Net income from sale | 19,7 | 24,3 | 29,2 | 20,5 |
Short time liabilities | 4,6 | 4 | 1,5 | -62,2 |
Working assets | 5,8 | 6,9 | 7,3 | 6,1 |
Equity capital | 2,2 | 3,4 | 5,3 | 54 |
Operating profit (EBIT) | 1,7 | 1,9 | 2,6 | 36,9 |
Depreciation | 0,6 | 0,9 | 0,8 | -11,4 |
% | % | % | p.p. | |
Profitability of capital | 57,7 | 36,1 | 35,1 | -1 |
Equity capital to total assets | 25,3 | 36,1 | 56,2 | 20,1 |
Gross profit margin | 8 | 6,9 | 8,5 | 1,6 |
EBITDA Margin | 11,9 | 11,6 | 11,7 | 0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 86 | 60 | 19 | -41 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Katner Szymon, Sea
Łomianki
Totalna Reklama
Warszawa
PROCREATIVE TOMASZ ŁYSEK
OPOLE
89 STUDIO Karol Zieliński
Krzyż Wielkopolski
Agencja Kreatywna CWU
Kraków
Promostrada Group sp. z o.o.
Warszawa
TIWOLI
Sicienko
Studio CREDO
MYSŁOWICE
"ESPER CENTER" sp. z o.o.
Warszawa